Bosutinib: A third generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia

Brittany G. Hill, Vamsi K. Kota, Hanna Jean Khoury

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Bosutinib: A third generation tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences